AngioDynamics Net Income 2010-2025 | ANGO

AngioDynamics net income from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

Historical Chart (TTM)

Click on chart icon to view chart
Click on table icon to view table

Quarterly

Click on chart icon to view chart
Click on table icon to view table

Quarterly - YOY Change

Click on chart icon to view chart
Click on table icon to view table

Annual

Click on chart icon to view chart
Click on table icon to view table

Annual % Change

Click on chart icon to view chart
Click on table icon to view table
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$216.7B
Thermo Fisher Scientific (TMO)$203.1B
Alcon (ALC)$44.2B
Edwards Lifesciences (EW)$44B
IDEXX Laboratories (IDXX)$36.9B
DexCom (DXCM)$35B
IQVIA Holdings (IQV)$34.6B
Mettler-Toledo (MTD)$27.3B
Waters (WAT)$22.4B
STERIS (STE)$21.8B
SONOVA HOLDING (SONVY)$19.6B
Hologic (HOLX)$14.4B
Fresenius Medical Care AG KGaA (FMS)$13.6B
Penumbra (PEN)$11.7B
Sysmex ADR (SSMXY)$11.5B
Globus Medical (GMED)$11.5B
Masimo (MASI)$9.6B
Glaukos (GKOS)$8.9B
Teleflex (TFX)$8.1B
Integer Holdings (ITGR)$4.8B
Inari Medical (NARI)$4.7B
PROCEPT BioRobotics (PRCT)$3.5B
Veracyte (VCYT)$3.3B
Nihon Kohden (NHNKY)$2.7B
TransMedics (TMDX)$2.7B
LivaNova (LIVN)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2.1B
Integra LifeSciences Holdings (IART)$1.7B
Alphatec Holdings (ATEC)$1.5B